Fundz

ProfoundBio Raises $112 Million in Oversubscribed Series B Equity Financing to Advance its Clinical-Stage Antibody-Drug Conjugate (ADC) Pipeline

PRIVATEFeb 13, 2024

Amount Raised

$112 Million

Round Type

Series B

WoodinvilleBiotechnology

Investors

Lilly Asia VenturesLife Sci Venture PartnersPiper Heartland Healthcare CapitalOctagon CapitalLogos CapitalMedicxiSurveyor CapitalLYFE CapitalOrbi MedRA Capital ManagementJanus Henderson InvestorsT. Rowe PriceNextech InvestAlly Bridge Group

Description

ProfoundBio announced an oversubscribed $112 million Series B financing, led by Ally Bridge Group, to advance its clinical-stage Antibody-Drug Conjugate (ADC) pipeline. The funding round also included world-class healthcare dedicated and mutual fund institutional investors.

Quick answer

ProfoundBio raised $112 Million in a Series B round, dated February 13, 2024. Investors: Lilly Asia Ventures, Life Sci Venture Partners, Piper Heartland Healthcare Capital, Octagon Capital, Logos Capital, Medicxi, Surveyor Capital and LYFE Capital. ProfoundBio is based in Woodinville, Washington, United States.

How much did ProfoundBio raise?
ProfoundBio raised $112 Million in a Series B round on February 13, 2024.
Who invested in ProfoundBio?
Lilly Asia Ventures, Life Sci Venture Partners, Piper Heartland Healthcare Capital, Octagon Capital, Logos Capital, Medicxi, Surveyor Capital and LYFE Capital are named as investors in this round.
What does ProfoundBio do?
ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
Where is ProfoundBio based and how big is it?
ProfoundBio is based in Woodinville, Washington, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as ProfoundBio that raised within 45 days of this round, from Fundz verified event records.

  • CESSATION THERAPEUTICS raised $1M (Seed) on March 29, 2024.
  • Vaccinex raised $1.8M (Seed) on March 29, 2024.
  • Terragia Biofuel raised $6M (Seed) on March 29, 2024.
  • Sense4Med raised $551K (Seed) on March 29, 2024.
  • Inomagen Therapeutics raised $200K (Pre-Seed) on March 29, 2024.
  • ProtoKinetix raised $35K (Seed) on March 29, 2024.

Who to call at ProfoundBio, and when

A new round usually means ProfoundBio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ProfoundBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ProfoundBio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ProfoundBio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ProfoundBio

Location

Woodinville, Washington, United States

About

ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on innovative technology platforms, ProfoundBio has developed a pipeline consisting of multiple solid tumor-targeting drug candidates that are currently in discovery and preclinical development stages. ProfoundBio has operations in both the greater Seattle area, WA, USA and Suzhou, China. For more information, please visit www.profoundbio.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ProfoundBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ProfoundBio's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

ProfoundBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.